Clover Health Investments, Corp.
CLOV
$2.49
$0.041.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.74B | 1.58B | 1.46B | 1.34B | 1.32B |
| Total Other Revenue | 37.02M | 27.91M | 26.48M | 25.78M | 24.09M |
| Total Revenue | 1.77B | 1.61B | 1.49B | 1.37B | 1.34B |
| Cost of Revenue | 1.40B | 1.22B | 1.09B | 1.01B | 1.01B |
| Gross Profit | 375.61M | 383.65M | 391.93M | 364.34M | 329.01M |
| SG&A Expenses | 431.66M | 424.71M | 414.84M | 408.93M | 401.79M |
| Depreciation & Amortization | 1.61M | 1.54M | 1.48M | 1.33M | 1.66M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.83B | 1.65B | 1.51B | 1.42B | 1.42B |
| Operating Income | -57.66M | -42.60M | -24.39M | -45.93M | -74.44M |
| Income Before Tax | -57.71M | -42.12M | -24.37M | -46.27M | -92.73M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57.71 | -42.12 | -24.37 | -46.27 | -92.73 |
| Earnings from Discontinued Operations | -611.00K | -981.00K | -743.00K | 3.26M | 1.34M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.32M | -43.10M | -25.11M | -43.01M | -91.39M |
| EBIT | -57.66M | -42.60M | -24.39M | -45.93M | -74.44M |
| EBITDA | -56.05M | -41.06M | -22.91M | -44.60M | -72.78M |
| EPS Basic | -0.12 | -0.09 | -0.05 | -0.09 | -0.19 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.03 | -0.06 | -0.10 |
| EPS Diluted | -0.12 | -0.09 | -0.06 | -0.09 | -0.19 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.03 | -0.06 | -0.10 |
| Average Basic Shares Outstanding | 2.01B | 1.99B | 1.97B | 1.96B | 1.95B |
| Average Diluted Shares Outstanding | 2.01B | 1.99B | 1.97B | 1.96B | 1.95B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |